Press Releases

MUNICH--(BUSINESS WIRE)-- Cypress Semiconductor Corp. (NASDAQ:CY), the embedded solutions leader, today announced it is expanding its Internet of Things (IoT) solutions portfolio with a new member of its ultra-low-power PSoC® 6 microcontroller (MCU) family. The new PSoC 6 MCU is purpose-built to address the growing needs for computing, connectivity and storage in IoT edge devices. The new MCUs in

MUNICH--(BUSINESS WIRE)-- Cypress Semiconductor Corp. (NASDAQ:CY), the embedded solutions leader, today introduced a nonvolatile data-logging solution with ultra-low power consumption. This solution is ideal for the latest-generation portable medical and wearable devices and other Internet of Things (IoT) applications that demand nonvolatile memories to continuously log an increasing amount of user and sensor d

SHANGHAI--(BUSINESS WIRE)-- Generon BioMed Holding Ltd announced the Phase IIa study results of “an open-label, cohort dose escalating study to assess the safety and efficacy of F-652 in patients with alcoholic hepatitis (AH)”. The results of this clinical study were presented at the American Association for the Study of Liver Diseases (AASLD) 2018 in San Francisco. The study was conducted by Dr. Vi

FRANKFURT, Germany--(BUSINESS WIRE)-- Optomec, a leading global supplier of production-grade additive manufacturing (AM) systems, today announced it w

SEOUL, South Korea--(BUSINESS WIRE)-- Hyosung (KRX:004800) Chairman Cho Hyun-Joon has dispelled a view of textile business as a declining industry. He has tackled global

LONDON--(BUSINESS WIRE)-- The global herpes zoster treatment market 2019-2023 is expected to post a CAGR of close to 14% during the forecast period, according to the latest market research report by

VAN NUYS, Calif.--(BUSINESS WIRE)-- Trio-Tech International (NYSE MKT: TRT) today announced financial results for the first quarter of fiscal 2019. For the three months ended September 30, 2018, revenue decreased 8% to $10,045,000 compared to revenue of $10,945,000 for the first quarter of fiscal 2018. Manufacturing revenue decreased to $3,637,000 from $4,765,000 last year, primarily due to lo

DALLAS--(BUSINESS WIRE)-- Mellanox Technologies, Ltd. (NASDAQ:MLNX), a leading supplier of high-performance, end-to-end smart interconnect solutions for data center servers and storage systems, today announced a collaborative effort with Los Alamos National Laboratory (LANL) to develop large scale, mission centric computing infrastructure. The organizations will focus on leveraging Mellanox In-Network Computing

RESTON, Va.--(BUSINESS WIRE)-- NCI Information Systems, Inc. (NCI), a leading provider of advanced information technology solutions and professional services to U.S. federal government agencies, today announced it has earned recognition as a

SAN DIEGO--(BUSINESS WIRE)-- As schools across America enter the holiday season, the opioid epidemic stands at an all-time high. Opioid overdoses are driving a

SANTA ANA, Calif.--(BUSINESS WIRE)-- Iteris, Inc. (NASDAQ:ITI), the global leader in applied informatics for transportation and agriculture, today announced that

AUSTIN, Texas--(BUSINESS WIRE)-- AEV Technologies, Inc., designer and manufacturer of compact, light-duty emissions-free electric vehicles for urban commercial, consumer and government markets, announces the launch of a new electric vehicle category with the release of the AEV 311. Now available for order, the street legal, three-wheeled inline two-seater is AEV’s 100 percent emissions-free, multi-pu

WALTHAM, Mass.--(BUSINESS WIRE)-- Mercy Ships clinicians aboard their floating hospital ship, the Africa Mercy, care for the world’s most vulnerable populations.

NEW YORK--(BUSINESS WIRE)-- Legend Merger Sub, Inc. (the “Offeror”), a wholly-owned subsidiary of RegionalCare Hospital Partners Holdings, Inc. (d/b/a RCCH Healthcare Partners) (“RCCH”), announced today preliminary results with respect to the Offeror’s previously announced tender offer to purchase for cash (the “Tender Offer”) any and all of LifePoint Health, Inc.’s (&ld

WILMINGTON, Del.--(BUSINESS WIRE)-- NeuroRx, a clinical stage biopharma company focused on the development of Rapid Acting Antidepressants (RAADs) that target the brain’s NMDA receptor, has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for development of NRX-101. The designation is for treatment of Severe Bipolar Depression with Acute Suicidal Ideation &am